Becton, Dickinson And Company
—- Market cap
- —
- Debt
- +$19.18B
- Cash
- −$641.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $223.02B · View financials
Decision snapshot: BDX stock price vs TMO: inconclusive — current versus $197.89 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TMO's multiple
Implied fair value · at BDX's multiple
Needs BDX P/E.
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
13 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BECTON, DICKINSON AND COMPANY · implied price per share
Bear
$42.31
Base
$61.15
Bull
$85.69
THERMO FISHER SCIENTIFIC INC. · implied price per share
Bear
$232.95
Base
$271.64
Bull
$310.46
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe BDX can sustain its 8.2% revenue growth while improving margins and reducing leverage closer to TMO levels, then a modestly constructive position is justified because the current price still sits below the P/E implied value of $188.41 and below TMO on several valuation multiples.
BDX trades at $165.62 versus a P/E implied price of $188.41, suggesting 13.8% upside on this framework. However, TMO-implied range is wide at $197.15 to $377.75, while BDX also sits within a lower historical band of $149.06 to $182.18 and a DCF range of $131.75 to $178.25, so the stock looks closer to fair value than deeply discounted.
Supporting Metrics